0001493152-21-004172.txt : 20210217
0001493152-21-004172.hdr.sgml : 20210217
20210217192427
ACCESSION NUMBER: 0001493152-21-004172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210215
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kanubaddi Avani
CENTRAL INDEX KEY: 0001838498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38286
FILM NUMBER: 21646987
MAIL ADDRESS:
STREET 1: C/O JAY PHARMA INC.
STREET 2: 4851 TAMIAMI TRAIL N, SUITE 200
CITY: NAPLES
STATE: FL
ZIP: 34103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enveric Biosciences, Inc.
CENTRAL INDEX KEY: 0000890821
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 954484725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200
CITY: NAPLES
STATE: FL
ZIP: 34103
BUSINESS PHONE: 239-302-1707
MAIL ADDRESS:
STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200
CITY: NAPLES
STATE: FL
ZIP: 34103
FORMER COMPANY:
FORMER CONFORMED NAME: AMERI Holdings, Inc.
DATE OF NAME CHANGE: 20150527
FORMER COMPANY:
FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC
DATE OF NAME CHANGE: 19950323
4
1
ownership.xml
X0306
4
2021-02-15
0
0000890821
Enveric Biosciences, Inc.
ENVB
0001838498
Kanubaddi Avani
C/O ENVERIC BIOSCIENCES, INC.
4851 TAMIAMI TRAIL N, SUITE 200
NAPLES
FL
34103
0
1
0
0
Chief Operating Officer
Restricted Stock Units
2021-02-15
4
A
0
789484
0
A
Common Stock
789484
789484
D
Represents restricted stock units granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan (the "Plan"). For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock upon termination of employment with or services to the Company or in connection with a change of control, as set forth in the reporting person's restricted stock unit award agreement.
One-third (1/3rd) of the restricted stock units vested as of December 30, 2020, and the remaining two-thirds (2/3rds) of the restricted stock units shall vest in three equal tranches, with the vesting of each tranche based on the achievement of a performance milestone established by the compensation committee of the board of directors of the Company for such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan.
/s/ Avani Kanubaddi
2021-02-17